Mimedx (MDXG) EBT (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -170.34% |
| Dec 31, 2025 | -4.61% |
| Sep 30, 2025 | 75.67% |
| Jun 30, 2025 | 51.03% |
| Mar 31, 2025 | -23.44% |
| Dec 31, 2024 | -1.49% |
| Sep 30, 2024 | -50.81% |
| Jun 30, 2024 | 103.49% |
| Mar 31, 2024 | -18.00% |
| Dec 31, 2023 | 47.49% |
| Sep 30, 2023 | 2.79% |
| Jun 30, 2023 | 585.30% |
| Mar 31, 2023 | -119.18% |
| Dec 31, 2022 | 217.74% |
| Sep 30, 2022 | 22.52% |
| Jun 30, 2022 | -3.64% |
| Mar 31, 2022 | -11,557.14% |
| Dec 31, 2021 | 104.47% |
| Sep 30, 2021 | -14.24% |
| Jun 30, 2021 | 78.57% |
| Mar 31, 2021 | 52.70% |
| Dec 31, 2020 | 9.18% |
| Sep 30, 2020 | -129.64% |
| Jun 30, 2020 | 47.67% |
| Mar 31, 2020 | -122.23% |
| Dec 31, 2019 | -160.12% |
| Sep 30, 2019 | 170.31% |
| Jun 30, 2019 | -29.76% |
| Mar 31, 2019 | -51.61% |
| Dec 31, 2018 | -1,948.94% |
| Sep 30, 2018 | -73.65% |
| Jun 30, 2018 | -41.60% |
| Mar 31, 2018 | -83.78% |
| Dec 31, 2017 | 44.65% |
| Sep 30, 2017 | 85.07% |
| Jun 30, 2017 | 16.95% |
| Mar 31, 2017 | 167.62% |
| Dec 31, 2016 | -293.50% |
| Sep 30, 2016 | 33.80% |
| Jun 30, 2016 | 144.51% |
| Mar 31, 2016 | -81.63% |
| Dec 31, 2015 | 14.52% |
| Sep 30, 2015 | 18.68% |
| Jun 30, 2015 | 33.55% |
| Mar 31, 2015 | -8.83% |
| Dec 31, 2014 | 24.74% |
| Sep 30, 2014 | 1,030.50% |
| Jun 30, 2014 | 56.14% |
| Mar 31, 2014 | 35.96% |
| Dec 31, 2013 | -446.84% |
| Sep 30, 2013 | 65.62% |
| Jun 30, 2013 | 51.76% |
| Mar 31, 2013 | 2.23% |
| Dec 31, 2012 | 61.94% |
| Sep 30, 2012 | -467.07% |
| Jun 30, 2012 | 31.96% |
| Mar 31, 2012 | 57.56% |
| Dec 31, 2011 | -45.96% |
| Sep 30, 2011 | 29.47% |
| Jun 30, 2011 | 25.21% |